The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.

Sassi M, Chakroun T, Mbemba E, Van Dreden P, Elalamy I, Larsen AK, Gerotziafas GT

Open source

DOI
10.1177/1076029616665922
Published
2017 Mar
Container
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1076029616665922,
  title = {The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.},
  author = {Sassi M and Chakroun T and Mbemba E and Van Dreden P and Elalamy I and Larsen AK and Gerotziafas GT},
  year = {2017},
  journal = {Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis},
  doi = {10.1177/1076029616665922},
  url = {https://doi.org/10.1177/1076029616665922}
}

RIS

TY  - JOUR
TI  - The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
AU  - Sassi M
AU  - Chakroun T
AU  - Mbemba E
AU  - Van Dreden P
AU  - Elalamy I
AU  - Larsen AK
AU  - Gerotziafas GT
PY  - 2017
JO  - Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
DO  - 10.1177/1076029616665922
UR  - https://doi.org/10.1177/1076029616665922
ER  - 

APA

M, S., T, C., E, M., P, V. D., I, E., AK, L., & GT, G. (2017). The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. https://doi.org/10.1177/1076029616665922

Source records